SCHEMBL5358301

SCHEMBL5358301

O=S1(=O)N=CN(CF)c2ccc(Cl)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA2 P42262 6/20 0.43
GRIA1 P42261 5/20 0.43
GRIA3 P42263 5/20 0.43
GRIA4 P48058 5/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KDM4E B2RXH2 1/20 0.39
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39
CA4 P22748 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
TP53 P04637 2/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 3/20 0.35
MAPT P10636 2/20 0.35
ALDH1A1 P00352 2/20 0.35
THRB P10828 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5361851 0.90 GRIA2 (0.48) GRIA2GRIA1GRIA3GRIA4NPSR1
SCHEMBL5355287 0.87 GRIA2 (0.43) GRIA2GRIA1GRIA3GRIA4NPSR1
SCHEMBL5355691 0.87 GRIA2 (0.43) GRIA2GRIA1GRIA3GRIA4NPSR1
SCHEMBL5352006 0.85 NPSR1 (0.42) GRIA2GRIA1GRIA3GRIA4NPSR1
SCHEMBL2775615 0.81 GRIA2 (0.40) GRIA2GRIA1GRIA3GRIA4NPSR1
SCHEMBL5356178 0.78 GRIA2 (0.42) GRIA2GRIA1GRIA3GRIA4NPSR1
SCHEMBL27845504 0.78 CA12 (0.47) GRIA2GRIA1GRIA3GRIA4KDM4E
SCHEMBL27621931 0.74 GRIA2 (0.35) GRIA2GRIA1GRIA3GRIA4NPSR1
SCHEMBL2777517 0.73 GRIA2 (0.48) GRIA2GRIA1GRIA3GRIA4CA12
SCHEMBL5349703 0.73 NPSR1 (0.50) GRIA2GRIA1GRIA3GRIA4NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268129-B2 Fluorinated benzothiadiazine compounds LES LABORATOIRES SERVIER (FR) 2007-09-11 US disclosed
CN-1308317-C New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2007-04-04 CN disclosed
CN-1680343-A New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2005-10-12 CN disclosed
US-20050165008-A1 Fluorinated benzothiadiazine compounds LES LABORATORIES SERVIER (FR) 2005-07-28 US disclosed
EP-1557412-A1 Fluorinated benzothiadiazine derivatives and their use as AMPA receptor modulators Les Laboratoires Servier (FR) 2005-07-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050165008-A1 Fluorinated benzothiadiazine compounds GRM1, GRIN1, GRIK5 GRIA2 50/4885GRIA1 47/4885GRIA3 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.